首页 | 本学科首页   官方微博 | 高级检索  
     

川芎嗪对人外周血淋巴细胞蛋白激酶C通道的影响
引用本文:刘先胜,徐永健,张珍祥,熊盛道,倪望.川芎嗪对人外周血淋巴细胞蛋白激酶C通道的影响[J].中国病理生理杂志,2003,19(4):507-510.
作者姓名:刘先胜  徐永健  张珍祥  熊盛道  倪望
作者单位:华中科技大学同济医学院附属同济医院呼吸内科, 湖北 武汉 430030
基金项目:教育部“高等院校骨干教师资助计划”2 0 0 0年度资助项目
摘    要:目的:探讨川芎嗪(LTZ)对正常人外周血淋巴细胞(PBL)蛋白激酶C(PKC)通道在受到与哮喘有关的炎症介质刺激时所发生的功能变化是否有影响。方法:取63例健康人外周静脉血各10mL,分离PBL,分4批分别给予以下处理后,采用-ATP催化活性测定法检测细胞胞膜、胞浆及总PKC活性。(1)分3组即5g/LLTZ处理组(6例)、5μmol/LPKC阻断剂Ro31-8220处理组(6例)和对照组(6例,以下各批均以此组为阴性对照组);(2)共3组分别用100nmol/L乙酰甲胆碱(Mch,5例)、5g/LLTZ+100nmol/LMch(5例)或5μmol/LRo31-8220+100nmol/LMch(5例)处理。(3)共3组分别采用100nmol/L组胺、5g/LLTZ+100nmol/L组胺(5例)或5μmol/LRo31-8220+100nmol/L组胺(5例)处理。(4)共3组分别用100nmol/LPMA(5例)、5g/LLTZ+100nmol/LPMA(5例)或5μmol/LRo31-8220+100nmol/LPMA(5例)。结果(1)LTZ对正常人PBL胞膜、胞浆及总PKC活性均无明显影响;(2)乙酰甲胆碱及组胺均可促进正常人PBL胞膜PKC活性增加,LTZ对该作用有抑制效应(P<0.05)。(3)LTZ对PMA诱发正常人PBL胞膜PKC活性增加的效应有抑制作用(P<0.05)。结论:川芎嗪对正常人PBLPKC通道在受到与哮喘有关的炎症介质刺激时所发生的活化有一定的抑制作用,该作用可能是川芎嗪对哮喘疾病具有防治意义的机制之一。

关 键 词:蛋白激酶C  川芎嗪  淋巴细胞  哮喘  
文章编号:1000-4718(2003)04-0507-04
收稿时间:2002-02-28

Effect of ligustrazine on protein kinase C signaling pathway in human peripheral blood lymphocytes
LIU Xian-sheng,XU Yong-jian,ZHANG Zhen-xiang,XIONG Sheng-dao,NI Wang.Effect of ligustrazine on protein kinase C signaling pathway in human peripheral blood lymphocytes[J].Chinese Journal of Pathophysiology,2003,19(4):507-510.
Authors:LIU Xian-sheng  XU Yong-jian  ZHANG Zhen-xiang  XIONG Sheng-dao  NI Wang
Affiliation:Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Abstract:AIM:To investigate whether Ligustrazine(LTZ) has an effect on the changes of protein kinase C(PKC) signaling pathway induced by inflammatory mediators involved in asthma in normal human peripheral blood lymphocytes (PBL).METHODS:10 mL peripheral venous blood was obtained from each of 63 health humans and treated as follows. The activities of PKC from cytosolic and membrane fractions in PBL were measured by -ATP-catalyzing assay, after PBL had been isolated and performed by following processes: (1) First: three groups treated with 5 g/L LTZ(n=6) or 5 μmol/L Ro31-8220 (n=6); Paired untreated PBL served as control of this group, as well as the negative controls of the following groups(n=6); (2)Second : three groups treated with 100 nmol/L Methacholine (Mch, n=5), 5 g/L LTZ+100nmol/L Mch(n=5)or 5 μmol/L Ro31-8220(a PKC inhibitor)+100 nmol/L Mch(n=5); (3)Third: three groups treated with 100 nmol/L histamine, 5 g/L LTZ+100 nmol/L histamine(n=5) or 5 μmol/L Ro31-8220+100nmol/L histamine(n=5); (4)Fourth: three groups treated respectively with 100nmol/L PMA(a PKC activator, n=5), 5 g/L LTZ+100nmol/L PMA(n=5) or 5 μmol/L Ro31-8220+100nmol/L PMA(n=5).RESULTS:(1)LTZ had no effect on the activities of PKC in inactive PBL in normal humans; (2) Methacholine or histamine resulted in an increase in membrane PKC activity of normal human PBL, which was partly suppressed by LTZ (all P<0.05); (3) PMA caused an increase in membrane PKC activity of normal human PBL, which was partly decreased by LTZ (all P<0.05).CONCLUSION:LTZ has an inhibitory effect on activation of PKC signaling pathway in PBL in normal humans induced by some inflammatory mediators involved in asthma, which may be one of the mechanisms that LTZ plays a role in the prevention and therapy of asthma.
Keywords:Protein kinase C  Ligustrazine  Lymphomcyte  Asthma
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号